Mark E. Layton

5 Patents

• US124271592025

  Hydroxypyrrolidine-substituted Arylsulfonamide Compounds with Selective Activity in Voltage-gated Sodium Channels

  Merck Sharp & Dohme LLC

  0 cites
• US123445952025

  2-amino-n-phenyl-nicotinamides as NAV1.8 Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US122460082025

  4-amino or 4-alkoxy-substituted Aryl Sulfonamide Compounds with Selective Activity in Voltage-gated Sodium Channels

  Merck Sharp & Dohme LLC

  0 cites
• US121954452025

  2-amino-n-heteroaryl-nicotinamides as Na V 1.8 Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US118021222023

  2-oxoimidazolidine-4-carboxamides as NA V 1.8 Inhibitors

  Merck Sharp & Dohme LLC

  0 cites